{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:58:59Z","timestamp":1789473539454,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA242559"],"award-info":[{"award-number":["R01 CA242559"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R37 CA222885"],"award-info":[{"award-number":["R37 CA222885"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.euf.2021.10.007","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T15:43:52Z","timestamp":1635176632000},"page":"1545-1552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Improving Guideline Adherence in Urology"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2691-8421","authenticated-orcid":false,"given":"Steven","family":"MacLennan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eilidh","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted A.","family":"Skolarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique J.","family":"Roobol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veeru","family":"Kasivisvanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Gandaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios","family":"Sakalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma Jane","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Plass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Ribal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"N'Dow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2021.10.007_b0005","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jclinepi.2014.12.015","article-title":"Quality of evidence is a key determinant for making a strong GRADE guidelines recommendation","volume":"68","author":"Djulbegovic","year":"2015","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.euf.2021.10.007_b0010","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.eururo.2017.08.016","article-title":"Key steps in conducting systematic reviews for underpinning clinical practice guidelines: methodology of the European Association of Urology","volume":"73","author":"Knoll","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2021.10.007_b0015","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/0140-6736(93)92244-N","article-title":"Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations","volume":"342","author":"Grimshaw","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.euf.2021.10.007_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/S1569-9056(19)31534-9","article-title":"EVOLVE: designing a model of meaningful patient involvement in guideline development","volume":"18","author":"Bjorkqvist","year":"2019","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.euf.2021.10.007_b0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.eururo.2017.02.008","article-title":"Changing current practice in urology: improving guideline development and implementation through stakeholder engagement","volume":"72","author":"MacLennan","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2021.10.007_b0030","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.eururo.2016.11.023","article-title":"Conflict of evidence: resolving discrepancies when findings from randomized controlled trials and meta-analyses disagree","volume":"71","author":"Sylvester","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2021.10.007_b0035","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.eururo.2012.02.039","article-title":"Systematic review of oncological outcomes following surgical management of localised renal cancer","volume":"61","author":"MacLennan","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2021.10.007_b0040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.juro.2012.03.006","article-title":"Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis","volume":"188","author":"Kim","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2021.10.007_b0045","doi-asserted-by":"crossref","unstructured":"MacLennan S, Lam T, Imamura M, et al. Re: Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. S. P. Kim, R. H. Thompson, S. A. Boorjian, C. J. Weight, L. C. Han, M. H. Murad, N. D. Shippee, P. J. Erwin, B. A. Costello, G. K. Chow and B. C. Leibovich. J Urol 2012;188:51\u201357. J Urol 2013;189:1166\u20137.","DOI":"10.1016\/j.juro.2012.10.025"},{"key":"10.1016\/j.euf.2021.10.007_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2018.04.003","article-title":"Risks and benefits of adjuvant radiotherapy after inguinal lymphadenectomy in node-positive penile cancer: a systematic review by the European Association of Urology Penile Cancer Guidelines Panel","volume":"74","author":"Robinson","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2021.10.007_b0055","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.eururo.2019.09.020","article-title":"EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel consensus statements for deferred treatment with curative intent for localised prostate cancer from an international collaborative study (DETECTIVE study)","volume":"76","author":"Lam","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2021.10.007_b0060","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/annonc\/mdz296","article-title":"EAU-ESMO consensus statements on the management of advanced and variant bladder cancer\u2014an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees","volume":"30","author":"Horwich","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.euf.2021.10.007_b0065","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41585-020-0324-x","article-title":"Introducing PIONEER: a project to harness big data in prostate cancer research","volume":"17","author":"Omar","year":"2020","journal-title":"Nat Rev Urol"},{"issue":"8 Suppl 2","key":"10.1016\/j.euf.2021.10.007_b0070","first-page":"II46","article-title":"Successes and failures in the implementation of evidence-based guidelines for clinical practice","volume":"39","author":"Grol","year":"2001","journal-title":"Med Care"},{"key":"10.1016\/j.euf.2021.10.007_b0075","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.eururo.2020.10.011","article-title":"IMAGINE-IMpact Assessment of Guidelines Implementation and Education: the next frontier for harmonising urological practice across Europe by improving adherence to guidelines","volume":"79","author":"Cornford","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2021.10.007_b0080","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13012-017-0628-2","article-title":"Assessing citation networks for dissemination and implementation research frameworks","volume":"12","author":"Skolarus","year":"2017","journal-title":"Implement Sci"},{"key":"10.1016\/j.euf.2021.10.007_b0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/chp.47","article-title":"Lost in knowledge translation: time for a map?","volume":"26","author":"Graham","year":"2006","journal-title":"J Contin Educ Health Prof"},{"key":"10.1016\/j.euf.2021.10.007_b0090","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1748-5908-4-50","article-title":"Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science","volume":"4","author":"Damschroder","year":"2009","journal-title":"Implement Sci"},{"key":"10.1016\/j.euf.2021.10.007_b0095","series-title":"The behaviour change wheel: a guide to designing interventions","author":"Michie","year":"2014"},{"key":"10.1016\/j.euf.2021.10.007_b0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13012-017-0605-9","article-title":"A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems","volume":"12","author":"Atkins","year":"2017","journal-title":"Implement Sci"},{"key":"10.1016\/j.euf.2021.10.007_b0105","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1002\/cncr.24311","article-title":"Treatment of non-muscle invading bladder cancer: do physicians in the United States practice evidence based medicine? The use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumors","volume":"115","author":"Madeb","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.euf.2021.10.007_b0110","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.juro.2012.08.044","article-title":"Understanding the use of immediate intravesical chemotherapy for patients with bladder cancer","volume":"188","author":"Burks","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2021.10.007_b0115","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.urology.2018.10.016","article-title":"Perioperative intravesical chemotherapy for patients with non-muscle invasive bladder cancer: understanding the extent of and sources of variation in guideline-recommended use","volume":"124","author":"Check","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.euf.2021.10.007_b0120","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00345-013-1142-z","article-title":"The use of immediate postoperative instillations of intravesical chemotherapy after TURBT of NMIBC among European countries","volume":"32","author":"Palou-Redorta","year":"2014","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2021.10.007_b0125","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/bju.12235","article-title":"Snapshot of transurethral resection of bladder tumours in the United Kingdom audit (STUKA)","volume":"112","author":"Gan","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2021.10.007_b0130","unstructured":"NHS National Services Scotland. Prostate cancer quality performance indicators (patients diagnosed between July 2015 and June 2018). Public Health Scotland; 2019. http:\/\/www.isdscotland.org\/Health-Topics\/Quality-Indicators\/Publications\/2019-12-17\/2019-12-17-Prostate-QPI-Report.pdf."},{"key":"10.1016\/j.euf.2021.10.007_b0135","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/bju.15336","article-title":"What influences adherence to guidance for postoperative instillation of intravesical chemotherapy to patients with bladder cancer?","volume":"128","author":"Dunsmore","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2021.10.007_b0140","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.urolonc.2020.06.013","article-title":"Low compliance to guidelines in nonmuscle-invasive bladder carcinoma: a systematic review","volume":"38","author":"Mori","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2021.10.007_b0145","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.eururo.2020.06.051","article-title":"Enhanced quality and effectiveness of transurethral resection of bladder tumour in non\u2013muscle-invasive bladder cancer: a multicentre real-world experience from Scotland\u2019s Quality Performance Indicators programme","volume":"78","author":"Mariappan","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2021.10.007_b0150","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/bmjqs-2018-008355","article-title":"Reinvigorating stagnant science: implementation laboratories and a meta-laboratory to efficiently advance the science of audit and feedback","volume":"28","author":"Grimshaw","year":"2019","journal-title":"BMJ Qual Saf"},{"key":"10.1016\/j.euf.2021.10.007_b0155","unstructured":"BURST Urology. Transurethral REsection and Single instillation intra-vesical chemotherapy Evaluation in bladder Cancer Treatment (RESECT): improving quality in TURBT surgery. http:\/\/www.bursturology.com\/Studies\/Resect\/Overview\/."},{"key":"10.1016\/j.euf.2021.10.007_b0160","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13012-018-0826-6","article-title":"Changing behaviour \u2018more or less\u2019\u2014do theories of behaviour inform strategies for implementation and de-implementation? A critical interpretive synthesis","volume":"13","author":"Patey","year":"2018","journal-title":"Implement Sci"},{"key":"10.1016\/j.euf.2021.10.007_b0165","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1136\/bmjqs-2014-003821","article-title":"\u2018Choosing wisely\u2019: a growing international campaign","volume":"24","author":"Levinson","year":"2015","journal-title":"BMJ Qual Saf"},{"key":"10.1016\/j.euf.2021.10.007_b0170","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/bju.13307","article-title":"Patterns of prescription and adherence to European Association of Urology guidelines on androgen deprivation therapy in prostate cancer: an Italian multicentre cross-sectional analysis from the Choosing Treatment for Prostate Cancer (CHOICE) study","volume":"117","author":"Morgia","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2021.10.007_b0175","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djj230","article-title":"Determinants of androgen deprivation therapy use for prostate cancer: role of the urologist","volume":"98","author":"Shahinian","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.euf.2021.10.007_b0180","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jamainternmed.2014.3028","article-title":"Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer","volume":"174","author":"Lu-Yao","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"3 Suppl 1","key":"10.1016\/j.euf.2021.10.007_b0185","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0090-4295(02)01560-1","article-title":"Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer","volume":"60","author":"Meng","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.euf.2021.10.007_b0190","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/annonc\/mds618","article-title":"Guideline-discordant androgen deprivation therapy in localized prostate cancer: patterns of use in the Medicare population and cost implications","volume":"24","author":"Kuykendal","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.euf.2021.10.007_b0195","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13012-018-0833-7","article-title":"De-implementation of low value castration for men with prostate cancer: protocol for a theory-based, mixed methods approach to minimizing low value androgen deprivation therapy (DeADT)","volume":"13","author":"Skolarus","year":"2018","journal-title":"Implement Sci"},{"key":"10.1016\/j.euf.2021.10.007_b0200","unstructured":"Skolarus TA, Forman J, Sparks JB, et al. Understanding de-implementation of low value castration for men with prostate cancer. In: Proceedings of the 12th Annual Conference on the Science of Dissemination and Implementation, National Institutes of Health & AcademyHealth, 2019, Arlington, VA, USA."},{"issue":"4","key":"10.1016\/j.euf.2021.10.007_b0205","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.1172","article-title":"Association between guideline-discordant prostate cancer imaging rates and health care service among veterans and Medicare recipients","volume":"1","author":"Makarov","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.euf.2021.10.007_b0210","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/651061","article-title":"Adherence to guidelines among Italian urologists on imaging preoperative staging of low-risk prostate cancer: results from the MIRROR (Multicenter Italian Report on Radical Prostatectomy Outcomes and Research) study","volume":"2012","author":"Simonato","year":"2012","journal-title":"Adv Urol"},{"key":"10.1016\/j.euf.2021.10.007_b0215","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13012-016-0484-5","article-title":"A qualitative study to understand guideline-discordant use of imaging to stage incident prostate cancer","volume":"11","author":"Makarov","year":"2016","journal-title":"Implement Sci"},{"key":"10.1016\/j.euf.2021.10.007_b0220","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.urology.2020.05.101","article-title":"A clinical reminder order check intervention to improve guideline-concordant imaging practices for men with prostate cancer: a pilot study","volume":"145","author":"Ciprut","year":"2020","journal-title":"Urology"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456921002790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456921002790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:56:18Z","timestamp":1762498578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456921002790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S2405456921002790"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2021.10.007","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving Guideline Adherence in Urology","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2021.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}